Cargando…
Interchangeability of the Assays Used to Assess the Activity of Anti-SARS-CoV-2 Monoclonal Antibodies
The recent global COVID-19 pandemic caused by SARS-CoV-2 lasted for over three years. A key measure in combatting this pandemic involved the measurement of the monoclonal antibody (mAb)-mediated inhibition of binding between the spike receptor-binding domain (RBD) and hACE2 receptor. Potency assessm...
Autores principales: | Hickerson, Brady T., Khalenkov, Alexey M., Xie, Tao, Frucht, David M., Scott, Dorothy E., Ilyushina, Natalia A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459467/ https://www.ncbi.nlm.nih.gov/pubmed/37632039 http://dx.doi.org/10.3390/v15081698 |
Ejemplares similares
-
Method for screening influenza neutralizing antibodies in crude human plasma and its derivatives using SPR
por: Khalenkov, Alexey M., et al.
Publicado: (2023) -
Comparison of the Antiviral Activity of Remdesivir, Chloroquine, and Interferon-β as Single or Dual Agents Against the Human Beta-Coronavirus OC43
por: Hickerson, Brady T., et al.
Publicado: (2023) -
Safety, Immunogenicity and Interchangeability of Biosimilar Monoclonal Antibodies and Fusion Proteins: A Regulatory Perspective
por: Kurki, Pekka, et al.
Publicado: (2021) -
The use of plant lectins to regulate H1N1 influenza A virus receptor binding activity
por: Lee, Nicolette, et al.
Publicado: (2018) -
Anti-SARS-CoV-2 neutralizing monoclonal antibodies: clinical pipeline
por: Tuccori, Marco, et al.
Publicado: (2020)